slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 63,751-63,780
Pages 2,605
Rows per page 30
Component
63,751-63,780 of 78,138
35
The slide uses a donut chart as a central hub to connect the three categories of directors.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
36
The matrix uses a 3x3 grid structure to categorize priorities. Icons represent People, Planet, Governance, and Profit.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
38
EP&L stands for Environmental Profit & Loss. The slide uses a bubble matrix to show impact distribution and a line chart to show intensity reduction over time.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
39
The slide highlights geographic concentration in Italy and the formalization of sustainability through specific standards and audit cycles.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
40
Includes a visual comparison of land footprint vs. restoration target.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
05
The slide uses a Gantt-style chart to show the progress of various drug candidates.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
The slide uses a circular flywheel diagram to represent the IP strategy and a horizontal bar chart to illustrate market exclusivity duration.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
Uses scientific visualization to illustrate the drug's impact on brain function.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Uses a nested circle diagram to visualize the funnel of patients from total prevalence to treatment non-responders.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide presents clinical trial data (STAI-G scores) over 24 weeks, highlighting significant symptom reduction and safety profile.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses a bar chart to bridge the gap between the problem (no drugs) and the solution (R(-)-MDMA alignment with patient needs).MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
23
The slide uses a bar chart to demonstrate the therapeutic index advantage of the R-enantiomer.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
24
The chart shows improvement in social anxiety at 1 month and 6 months, indicating durability of effect.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
07
The slide uses a Gantt-style chart to visualize clinical trial progress for seven distinct programs.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
09
The slide uses a comparative structure to justify the strategic shift in trial design post-acquisition.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · ComplicationLoop · Cost Of Inaction1 hit
18
The slide uses a 'Signal Seeking' framework to justify clinical development decisions based on effect size.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
05
The slide uses a hub-and-spoke diagram to represent the portfolio segments around a central 'Full Continuum of Care' concept.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
11
The slide uses a donut chart to show revenue composition and highlights global reach.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Business ModelLoop · Golden Circle1 hit
13
Uses a pendulum metaphor to illustrate patient maturity and its impact on profitability.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Action1 hit
16
The chart highlights the acquisition of Crestmark in 2018.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit
06
The slide uses a Gantt-style visualization for drug development stages.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
13
The slide uses a Kaplan-Meier curve to contrast Lutathera against a control group, highlighting the clinical limitation of the current standard of care.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The chart compares median progression vs median survival in months across three patient cohorts (Pancreatic, GI, Overall).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
18
Waterfall plot displays individual patient responses; benchmarking table compares ORR against historical standards.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
19
The chart tracks patient follow-up in weeks, with markers indicating dose, dose reduction, and clinical response (Partial Response, Progressive Disease, Stable Disease).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
22
The slide uses a three-column layout to break down the market opportunity into patient population, pricing, and launch dynamics.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · Market Sizing1 hit
23
The slide highlights that 47% of SCLC samples show some level of SSTR2 expression, with 27% showing high expression.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
25
The chart shows tumor growth over 57 days across four treatment groups, with the combination therapy (green line) demonstrating the most effective tumor suppression.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
27
Includes PET scan imagery and a pharmacokinetic tumor uptake graph comparing RAYZ-SSTR to DOTATATE.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
31
Includes IHC staining images and a waterfall plot showing tumor shrinkage.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit